GUCY2C ligand supplementation decreases intestinal permeability and susceptibility to DSS-induced colitis. by Jieru Egeria Lin (181534)

RhoC overexpression in MCF10A cells results in a decrease in WISP3 mRNA level by Celina G Kleer (2440)

“…<p><b>Copyright information:</b></p><p>Taken from "WISP3 and RhoC guanosine triphosphatase cooperate in the development of inflammatory breast cancer"</p><p>Breast Cancer Research 2003;6(2):R110-R115.…”

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

Transfer of RSV-infected <i>Kdm5b</i>-deficient DCs leads to a decreased pathogenic pulmonary RSV challenge. by Catherine Ptaschinski (756139)

Fusion protein induction is correlated with a decrease in the level of FasII protein by Alberto Pascual (6762)

“…Immunostaining with anti-FasII antibodies revealed a decreased amount of the FasII protein (arrowhead). …”

Meltrin β does not affect the expression of EphA4 on the cell surface nor the initial association between ephrin-A5 and EphA4, but decreases accessibility of antibodies that recognize the EphA4 C-terminus. by Norihiro Yumoto (270290)

Subjects:

Associations between characteristics of Stories for Change Diabetes participants and meaningful decrease in hemoglobin A1c (HbA1c) from baseline to 3 months (N = 227).^a... by Abby M. Lohr (11263772)

Subjects:

Overexpression of miR-132-3p inhibits the TGF-<i>β</i>1/Smad2/3 signaling pathway in TGF-<i>β</i>1 induced MET-5A cells. by Yangyang Yin (14323701)

Subjects:

Decreases in muscle size, muscle force, and TB mass in 3-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Six weeks of voluntary wheel running decreases 5-HT_2C mRNA expression in the medial dorsal striatum. by Benjamin N. Greenwood (295216)

The LCS stream is absent in E16.5 <i>Emx1</i>-cKO mice. by Sathish Venkataramanappa (10331993)

POS treatment decreases ROS level and upregulates mitochondrial biogenesis in ARPE-19 cells through PGC-1α. by Murilo F. Roggia (755997)

“…<b>(B)</b> POS treatment downregulated the Intracellular ROS levels evaluated by H₂DCFDA. Mean ± SEM, n = 6 per group, two-tailed Student’s <i>t</i>-test, **<i>P</i> < 0.01, ***<i>P</i> < 0.001; ns, not significant. …”

Overexpression of CCP5A and CCP5B induced flagellum length decrease and cell cycle defects. by Louise Basmaciyan (4576624)

Decrease of cell viability and alterations of cell membrane permeability by infection with rotavirus isolates. by Carlos A. Guerrero (1264551)

BMDCs produce decreased amounts of IL-23 and IL-6 and become poor stimulators for Th17 after exposure to oxATP in culture. by Ronglan Zhao (658986)

AMS scores decrease over three days at high-altitude. by Erica C. Heinrich (6832055)

Dexamethasone decreases PGC-1α protein expression and transcription. by Jill A. Rahnert (2872766)

“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”

Treatment with C2IN-C3lim decreases the resorption of synthetic calcium phosphate surfaces by already differentiated osteoclasts. by Andrea Tautzenberger (502772)

Subjects:

GluN2A(D731N) decreases current amplitudes and shortens synaptic-like response time course. by Kai Gao (120150)

Overexpression of E2 decreases ORC2 occupancy at a known mammalian origin. by Marsha DeSmet (2513767)